United Therapeutics (UTHR) Price/FCF Ratio: History & Chart

United Therapeutics Corporation (UTHR)UTHRUnited Therapeutics Corporation

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.

Silver Spring, MD

1,400 employees

www.unither.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martine A. Rothblatt

View full financials

UTHR Price/FCF Ratio Metrics

PRICE/FCF RATIO

24.30

PRICE/FCF RATIO AVG TTM

21.56

PRICE/FCF RATIO AVG 3Y

18.33

PRICE/FCF RATIO AVG 5Y

17.57

PRICE/FCF RATIO AVG 10Y

14.80

PRICE/FCF RATIO AVG 15Y

15.29

PRICE/FCF RATIO AVG 20Y

16.44

CURRENT VS TTM AVG

+12.73%

CURRENT VS 3Y AVG

+32.55%

CURRENT VS 5Y AVG

+38.33%

CURRENT VS 10Y AVG

+64.16%

CURRENT VS 15Y AVG

+58.95%

CURRENT VS 20Y AVG

+47.83%

SECTOR MEDIAN · HEALTHCARE

20.41

median of 74 covered companies

CURRENT VS SECTOR MEDIAN

+19.06%

vs the sector median at left

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
United Therapeutics Corporation (UTHR)	$22.23B	24.30	21.56	18.33	17.57
Moderna, Inc. (MRNA)vs ›	$22.14B	N/A	28.07	27.23	27.23
STERIS plc (STE)vs ›	$22.45B	22.10	25.13	32.68	40.09
BioNTech SE (BNTX)vs ›	$23.38B	15.64	29.44	11.72	14.37
Viatris Inc. (VTRS)vs ›	$20.80B	12.28	8.96	7.29	6.78
West Pharmaceutical Services, Inc. (WST)vs ›	$23.72B	54.06	49.81	59.76	65.10
Waters Corporation (WAT)vs ›	$25.02B	119.44	50.68	42.72	40.52
Labcorp Holdings Inc. (LH)vs ›	$25.77B	18.04	17.16	19.69	16.03
Zimmer Biomet Holdings, Inc. (ZBH)vs ›	$18.52B	9.82	11.34	17.83	19.41
Incyte Corporation (INCY)vs ›	$25.96B	14.09	16.34	108.02	73.77

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

United Therapeutics Corporation (UTHR)

$22.23B

24.30

21.56

18.33

17.57

Moderna, Inc. (MRNA)vs ›

$22.14B

N/A

28.07

27.23

STERIS plc (STE)vs ›

$22.45B

22.10

25.13

32.68

40.09

BioNTech SE (BNTX)vs ›

$23.38B

15.64

29.44

11.72

14.37

Viatris Inc. (VTRS)vs ›

$20.80B

12.28

8.96

7.29

6.78

West Pharmaceutical Services, Inc. (WST)vs ›

$23.72B

54.06

49.81

59.76

65.10

Waters Corporation (WAT)vs ›

$25.02B

119.44

50.68

42.72

40.52

Labcorp Holdings Inc. (LH)vs ›

$25.77B

18.04

17.16

19.69

16.03

Zimmer Biomet Holdings, Inc. (ZBH)vs ›

$18.52B

9.82

11.34

17.83

19.41

Incyte Corporation (INCY)vs ›

$25.96B

14.09

16.34

108.02

73.77

Price/FCF Ratio FAQ

What is the Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The Price/FCF ratio for UTHR stock is 24.30.

Is United Therapeutics Corporation's Price/FCF ratio high or low?

The Price/FCF ratio of 24.30 is 36% above its 5-year average of 17.91, near the high end of its 5-year range (11.91–27.70).

What is the TTM average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The TTM average Price/FCF ratio for UTHR stock is 21.56.

What is the 3Y average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The 3Y average Price/FCF ratio for UTHR stock is 18.33.

What is the 5Y average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The 5Y average Price/FCF ratio for UTHR stock is 17.57.

What is the 10Y average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The 10Y average Price/FCF ratio for UTHR stock is 14.80.

What is the 15Y average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The 15Y average Price/FCF ratio for UTHR stock is 15.29.

What is the 20Y average Price/FCF ratio for United Therapeutics Corporation (UTHR)?

The 20Y average Price/FCF ratio for UTHR stock is 16.44.

DATE	PRICE/FCF RATIO
2026-07-28	24.30
2026-07-27	24.50
2026-07-24	24.53
2026-07-23	24.58
2026-07-22	24.46
2026-07-21	24.87
2026-07-20	24.57
2026-07-17	24.86
2026-07-16	24.56
2026-07-15	24.68
2026-07-14	24.45
2026-07-13	24.86
2026-07-10	25.39
2026-07-09	25.64
2026-07-08	25.73
2026-07-07	26.16
2026-07-06	25.40
2026-07-02	25.80
2026-07-01	25.40
2026-06-30	25.15
2026-06-29	25.29
2026-06-26	25.19
2026-06-25	25.22
2026-06-24	25.52
2026-06-23	25.27
2026-06-22	24.99
2026-06-18	24.91
2026-06-17	25.60
2026-06-16	25.45
2026-06-15	25.51
2026-06-12	25.34
2026-06-11	25.32
2026-06-10	25.25
2026-06-09	25.67
2026-06-08	25.28
2026-06-05	25.52
2026-06-04	25.42
2026-06-03	25.50
2026-06-02	25.07
2026-06-01	25.28
2026-05-29	25.85
2026-05-28	26.09
2026-05-27	26.49
2026-05-26	26.85
2026-05-22	26.38
2026-05-21	26.27
2026-05-20	26.18
2026-05-19	26.31
2026-05-18	26.32
2026-05-15	26.39
2026-05-14	26.73
2026-05-13	26.90
2026-05-12	27.00
2026-05-11	26.45
2026-05-08	26.22
2026-05-07	26.42
2026-05-06	27.70
2026-05-05	26.34
2026-05-04	26.75
2026-05-01	26.25
2026-04-30	26.30
2026-04-29	26.28
2026-04-28	26.19
2026-04-27	26.10
2026-04-24	26.10
2026-04-23	26.37
2026-04-22	26.43
2026-04-21	26.39
2026-04-20	26.39
2026-04-17	27.08
2026-04-16	26.72
2026-04-15	26.58
2026-04-14	26.63
2026-04-13	26.59
2026-04-10	26.31
2026-04-09	26.45
2026-04-08	26.77
2026-04-07	26.04
2026-04-06	25.76
2026-04-02	26.00
2026-04-01	26.25
2026-03-31	27.29
2026-03-30	27.08
2026-03-27	24.06
2026-03-26	24.51
2026-03-25	24.93
2026-03-24	24.48
2026-03-23	23.99
2026-03-20	24.13
2026-03-19	24.26
2026-03-18	24.41
2026-03-17	24.86
2026-03-16	24.59
2026-03-13	24.68
2026-03-12	24.52
2026-03-11	25.07
2026-03-10	24.66
2026-03-09	24.36
2026-03-06	22.01
2026-03-05	22.33
2026-03-04	22.56
2026-03-03	22.95
2026-03-02	23.65
2026-02-27	23.19
2026-02-26	23.18
2026-02-25	24.63
2026-02-24	19.96
2026-02-23	20.01
2026-02-20	19.96
2026-02-19	20.26
2026-02-18	20.07
2026-02-17	20.34
2026-02-13	19.97
2026-02-12	20.07
2026-02-11	20.06
2026-02-10	19.95
2026-02-09	19.95
2026-02-06	20.46
2026-02-05	20.19
2026-02-04	20.35
2026-02-03	20.16
2026-02-02	20.03
2026-01-30	19.79
2026-01-29	19.72
2026-01-28	19.70
2026-01-27	20.10
2026-01-26	19.96
2026-01-23	19.77
2026-01-22	19.90
2026-01-21	19.81
2026-01-20	19.73
2026-01-16	19.60
2026-01-15	19.90
2026-01-14	20.06
2026-01-13	20.10
2026-01-12	20.34
2026-01-09	20.37
2026-01-08	20.69
2026-01-07	21.24
2026-01-06	21.19
2026-01-05	20.65
2026-01-02	20.94
2025-12-31	20.54
2025-12-30	20.92
2025-12-29	21.20
2025-12-26	21.38
2025-12-24	21.70
2025-12-23	21.52
2025-12-22	21.66
2025-12-19	21.80
2025-12-18	21.38
2025-12-17	21.54
2025-12-16	21.08
2025-12-15	21.09
2025-12-12	20.83
2025-12-11	20.60
2025-12-10	20.44
2025-12-09	20.08
2025-12-08	20.22
2025-12-05	20.63
2025-12-04	20.41
2025-12-03	20.28
2025-12-02	19.99
2025-12-01	20.23
2025-11-28	20.49
2025-11-26	20.59
2025-11-25	20.48
2025-11-24	20.12
2025-11-21	20.02
2025-11-20	20.01
2025-11-19	20.09
2025-11-18	20.09
2025-11-17	19.90
2025-11-14	19.66
2025-11-13	19.49
2025-11-12	19.46
2025-11-11	19.36
2025-11-10	19.14
2025-11-07	18.93
2025-11-06	19.14
2025-11-05	18.86
2025-11-04	18.44
2025-11-03	18.49
2025-10-31	18.78
2025-10-30	19.12
2025-10-29	19.20
2025-10-28	18.73
2025-10-27	18.99
2025-10-24	18.88
2025-10-23	19.22
2025-10-22	19.02
2025-10-21	19.06
2025-10-20	19.51
2025-10-17	19.54
2025-10-16	19.51
2025-10-15	19.49
2025-10-14	19.55
2025-10-13	19.85
2025-10-10	19.84
2025-10-09	20.09
2025-10-08	20.25
2025-10-07	20.60
2025-10-06	20.44
2025-10-03	20.43
2025-10-02	20.00
2025-10-01	19.76
2025-09-30	18.91
2025-09-29	19.14
2025-09-26	19.51
2025-09-25	19.19
2025-09-24	19.79
2025-09-23	19.58
2025-09-22	18.70
2025-09-19	18.83
2025-09-18	18.48
2025-09-17	18.21
2025-09-16	17.95
2025-09-15	18.18
2025-09-12	18.27
2025-09-11	18.26
2025-09-10	17.88
2025-09-09	18.21
2025-09-08	17.80
2025-09-05	18.06
2025-09-04	17.16
2025-09-03	17.65
2025-09-02	18.26
2025-08-29	13.74
2025-08-28	13.86
2025-08-27	13.77
2025-08-26	13.95
2025-08-25	13.77
2025-08-22	14.08
2025-08-21	14.01
2025-08-20	13.82
2025-08-19	14.13
2025-08-18	14.17
2025-08-15	14.12
2025-08-14	14.07
2025-08-13	13.97
2025-08-12	13.59
2025-08-11	13.55
2025-08-08	13.60
2025-08-07	13.50
2025-08-06	13.64
2025-08-05	13.75
2025-08-04	13.20
2025-08-01	13.27
2025-07-31	12.39
2025-07-30	12.72
2025-07-29	12.81
2025-07-28	12.84
2025-07-25	13.11
2025-07-24	13.19
2025-07-23	13.16
2025-07-22	12.83
2025-07-21	12.62
2025-07-18	12.57
2025-07-17	12.80
2025-07-16	12.84

DATE

PRICE/FCF RATIO

2026-07-28

24.30

2026-07-27

24.50

2026-07-24

24.53

2026-07-23

24.58

2026-07-22

24.46

2026-07-21

24.87

2026-07-20

24.57

2026-07-17

24.86

2026-07-16

24.56

2026-07-15

24.68

2026-07-14

24.45

2026-07-13

24.86

2026-07-10

25.39

2026-07-09

25.64

2026-07-08

25.73

2026-07-07

26.16

2026-07-06

25.40

2026-07-02

25.80

2026-07-01

25.40

2026-06-30

25.15

2026-06-29

25.29

2026-06-26

25.19

2026-06-25

25.22

2026-06-24

25.52

2026-06-23

25.27

2026-06-22

24.99

2026-06-18

24.91

2026-06-17

25.60

2026-06-16

25.45

2026-06-15

25.51

2026-06-12

25.34

2026-06-11

25.32

2026-06-10

25.25

2026-06-09

25.67

2026-06-08

25.28

2026-06-05

25.52

2026-06-04

25.42

2026-06-03

25.50

2026-06-02

25.07

2026-06-01

25.28

2026-05-29

25.85

2026-05-28

26.09

2026-05-27

26.49

2026-05-26

26.85

2026-05-22

26.38

2026-05-21

26.27

2026-05-20

26.18

2026-05-19

26.31

2026-05-18

26.32

2026-05-15

26.39

2026-05-14

26.73

2026-05-13

26.90

2026-05-12

27.00

2026-05-11

26.45

2026-05-08

26.22

2026-05-07

26.42

2026-05-06

27.70

2026-05-05

26.34

2026-05-04

26.75

2026-05-01

26.25

2026-04-30

26.30

2026-04-29

26.28

2026-04-28

26.19

2026-04-27

26.10

2026-04-24

26.10

2026-04-23

26.37

2026-04-22

26.43

2026-04-21

26.39

2026-04-20

26.39

2026-04-17

27.08

2026-04-16

26.72

2026-04-15

26.58

2026-04-14

26.63

2026-04-13

26.59

2026-04-10

26.31

2026-04-09

26.45

2026-04-08

26.77

2026-04-07

26.04

2026-04-06

25.76

2026-04-02

26.00

2026-04-01

26.25

2026-03-31

27.29

2026-03-30

27.08

2026-03-27

24.06

2026-03-26

24.51

2026-03-25

24.93

2026-03-24

24.48

2026-03-23

23.99

2026-03-20

24.13

2026-03-19

24.26

2026-03-18

24.41

2026-03-17

24.86

2026-03-16

24.59

2026-03-13

24.68

2026-03-12

24.52

2026-03-11

25.07

2026-03-10

24.66

2026-03-09

24.36

2026-03-06

22.01

2026-03-05

22.33

2026-03-04

22.56

2026-03-03

22.95

2026-03-02

23.65

2026-02-27

23.19

2026-02-26

23.18

2026-02-25

24.63

2026-02-24

19.96

2026-02-23

20.01

2026-02-20

19.96

2026-02-19

20.26

2026-02-18

20.07

2026-02-17

20.34

2026-02-13

19.97

2026-02-12

20.07

2026-02-11

20.06

2026-02-10

19.95

2026-02-09

19.95

2026-02-06

20.46

2026-02-05

20.19

2026-02-04

20.35

2026-02-03

20.16

2026-02-02

20.03

2026-01-30

19.79

2026-01-29

19.72

2026-01-28

19.70

2026-01-27

20.10

2026-01-26

19.96

2026-01-23

19.77

2026-01-22

19.90

2026-01-21

19.81

2026-01-20

19.73

2026-01-16

19.60

2026-01-15

19.90

2026-01-14

20.06

2026-01-13

20.10

2026-01-12

20.34

2026-01-09

20.37

2026-01-08

20.69

2026-01-07

21.24

2026-01-06

21.19

2026-01-05

20.65

2026-01-02

20.94

2025-12-31

20.54

2025-12-30

20.92

2025-12-29

21.20

2025-12-26

21.38

2025-12-24

21.70

2025-12-23

21.52

2025-12-22

21.66

2025-12-19

21.80

2025-12-18

21.38

2025-12-17

21.54

2025-12-16

21.08

2025-12-15

21.09

2025-12-12

20.83

2025-12-11

20.60

2025-12-10

20.44

2025-12-09

20.08

2025-12-08

20.22

2025-12-05

20.63

2025-12-04

20.41

2025-12-03

20.28

2025-12-02

19.99

2025-12-01

20.23

2025-11-28

20.49

2025-11-26

20.59

2025-11-25

20.48

2025-11-24

20.12

2025-11-21

20.02

2025-11-20

20.01

2025-11-19

20.09

2025-11-18

20.09

2025-11-17

19.90

2025-11-14

19.66

2025-11-13

19.49

2025-11-12

19.46

2025-11-11

19.36

2025-11-10

19.14

2025-11-07

18.93

2025-11-06

19.14

2025-11-05

18.86

2025-11-04

18.44

2025-11-03

18.49

2025-10-31

18.78

2025-10-30

19.12

2025-10-29

19.20

2025-10-28

18.73

2025-10-27

18.99

2025-10-24

18.88

2025-10-23

19.22

2025-10-22

19.02

2025-10-21

19.06

2025-10-20

19.51

2025-10-17

19.54

2025-10-16

19.51

2025-10-15

19.49

2025-10-14

19.55

2025-10-13

19.85

2025-10-10

19.84

2025-10-09

20.09

2025-10-08

20.25

2025-10-07

20.60

2025-10-06

20.44

2025-10-03

20.43

2025-10-02

20.00

2025-10-01

19.76

2025-09-30

18.91

2025-09-29

19.14

2025-09-26

19.51

2025-09-25

19.19

2025-09-24

19.79

2025-09-23

19.58

2025-09-22

18.70

2025-09-19

18.83

2025-09-18

18.48

2025-09-17

18.21

2025-09-16

17.95

2025-09-15

18.18

2025-09-12

18.27

2025-09-11

18.26

2025-09-10

17.88

2025-09-09

18.21

2025-09-08

17.80

2025-09-05

18.06

2025-09-04

17.16

2025-09-03

17.65

2025-09-02

18.26

2025-08-29

13.74

2025-08-28

13.86

2025-08-27

13.77

2025-08-26

13.95

2025-08-25

13.77

2025-08-22

14.08

2025-08-21

14.01

2025-08-20

13.82

2025-08-19

14.13

2025-08-18

14.17

2025-08-15

14.12

2025-08-14

14.07

2025-08-13

13.97

2025-08-12

13.59

2025-08-11

13.55

2025-08-08

13.60

2025-08-07

13.50

2025-08-06

13.64

2025-08-05

13.75

2025-08-04

13.20

2025-08-01

13.27

2025-07-31

12.39

2025-07-30

12.72

2025-07-29

12.81

2025-07-28

12.84

2025-07-25

13.11

2025-07-24

13.19

2025-07-23

13.16

2025-07-22

12.83

2025-07-21

12.62

2025-07-18

12.57

2025-07-17

12.80

2025-07-16

12.84

Price/FCF Ratio: 24.30

UTHR Price/FCF Ratio Chart

UTHR Average Price/FCF Ratio Chart

UTHR Current vs Average Price/FCF Ratio Chart

UTHR Price/FCF Ratio Metrics

UTHR Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

UTHR Price/FCF Ratio History

Related Metrics